LENQUO Trademark

Trademark Overview

On Monday, December 16, 2019, a trademark application was filed for LENQUO with the United States Patent and Trademark Office. The USPTO has given the LENQUO trademark a serial number of 88728807. The federal status of this trademark filing is REGISTERED as of Tuesday, September 21, 2021. This trademark is owned by Glaxo Group Limited. The LENQUO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, psychiatric and immune system related diseases and disorders; vaccines
lenquo

General Information

Serial Number88728807
Word MarkLENQUO
Filing DateMonday, December 16, 2019
Status700 - REGISTERED
Status DateTuesday, September 21, 2021
Registration Number6488985
Registration DateTuesday, September 21, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 6, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, psychiatric and immune system related diseases and disorders; vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 19, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Friday, October 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 6, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 6, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 21, 2021REGISTERED-PRINCIPAL REGISTER
Sunday, August 15, 2021EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, May 5, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, April 6, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 6, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 4, 2021ELECTRONIC RECORD REVIEW COMPLETE
Friday, February 26, 2021ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, February 24, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 19, 2021EXAMINER'S AMENDMENT ENTERED
Friday, February 19, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, February 19, 2021EXAMINERS AMENDMENT E-MAILED
Friday, February 19, 2021EXAMINERS AMENDMENT -WRITTEN
Saturday, February 6, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 5, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 5, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, October 1, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, October 1, 2020LETTER OF SUSPENSION E-MAILED
Thursday, October 1, 2020SUSPENSION LETTER WRITTEN
Saturday, September 19, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 18, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 18, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 18, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 18, 2020NON-FINAL ACTION E-MAILED
Wednesday, March 18, 2020NON-FINAL ACTION WRITTEN
Sunday, March 15, 2020ASSIGNED TO EXAMINER
Thursday, December 19, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 19, 2019NEW APPLICATION ENTERED

Related Keywords

lenquo disorders pharmaceutical treatment diseases preparations substances ophthalmic respiratory hepatological neurological